Distance Learning Center

Educating and Connecting the Health Law Community.

Significant False Claims Act Case Law Developments and Preparing for FCA Enforcement in the Post-COVID-19 World - On Demand Recording

Recorded On: 05/27/2020

Time: 90 minutes
Session Format: On Demand Recording
CLE Credit Available:  No

We do not apply for CLE credit or issue CLE certificates for our past programs and webinar recordings. Please check with your State Bar as to whether self-study credits can be awarded - CLE credit may be obtained by applying directly to the attorney’s state accrediting body, but approval is not guaranteed and is at the discretion of said accrediting body

For on-demand webinar recordings, streaming access is available for 12-months from the date of the live webinar.  After 12-months, on-demand webinar recordings are available through the AHLA Health Law Archive.

The FCA is the federal government’s primary weapon to combat allegations of fraud and abuse in its programs. This presentation will cover two areas. One is to address significant new trends that have emerged regarding FCA enforcement, such as how circuit courts have split regarding whether reasonable clinical judgment can form the basis of an FCA action, whether claims can be materially false if the government does not routinely seek repayment through administrative action, and when violations of the Anti-Kickback law and Stark law can constitute a violation of the FCA. A second area is to address the likely enforcement actions the government or qui tam relators will undertake stemming from government funding related to the COVID-19 and steps healthcare entities can undertake to reduce exposure to liability.

Level of Difficulty: Intermediate

  • AHLA Member: $99
  • Non-AHLA Member: $149

Content Lead:

  • Fraud and Abuse

Robert S. Salcido

Partner

Akin Gump Strauss Hauer & Feld LLP
Washington, DC
Bio

Components visible upon registration.
Privacy Policy Terms of Use

American Health Law Association is a 501(c)3 and donations are tax-deductible to the extent allowed by law. EIN: 23-7333380B
© 2020 American Health Law Association. All rights reserved.